Timolol 0.5% Wockhardt

Quick links

Choose a section

Quick links to important sections

Advertisements

Timolol 0.5% Wockhardt

Advertisements
Advertisements

Overview of Timolol 0.5% Wockhardt

Property Description
Active ingredient Timolol maleate
Form Ophthalmic solution (Eye drops)
Pharmacological class Non-selective beta-adrenoceptor blocking agent
Common use Reduction and control of intraocular pressure (IOP)
Origin Synthetic

Timolol 0.5% Wockhardt is a synthetic, single-component medicine presented as a sterile ophthalmic solution (eye drops) manufactured by Wockhardt. Containing the active pharmaceutical ingredient, Timolol maleate, at a concentration of 0.5% w/v in an aqueous solution, this specific preparation is a prescription-only medicine designed for precise topical application to the eye.

Timolol 0.5% Wockhardt: Pharmaceutical Class and Composition

The medicine is pharmacologically classified as a non-selective beta-adrenoceptor blocking agent, a class of ocular hypotensive agents. Timolol is an antiglaucoma preparation that operates via beta-blockade. The active chemical compound, Timolol maleate, is a synthetic substance that belongs to the broader pharmacological group of beta-adrenoceptor blocking agents. As an ophthalmic solution, the preparation is designed for local use, ensuring the active component is delivered directly to the ocular surface, contrasting its action with systemic medications.

General Purpose of Timolol Ophthalmic Solution

The fundamental purpose of this ophthalmic preparation is the reduction and sustained control of elevated pressure within the eye, known as intraocular pressure (IOP). The functional principle involves modulating cellular signaling pathways in the eye's ciliary body, a process that decreases the rate of aqueous humor formation. By limiting the production of this internal fluid, Timolol helps maintain a lower, stable IOP, which is central to its therapeutic role in safeguarding ocular health.

Regulatory References

  1. Summary of Product Characteristics (SmPC)
Advertisements

What side effects are possible with Timolol 0.5% Wockhardt?

Timolol 0.5% Wockhardt is an ophthalmic solution containing the beta-adrenoceptor blocking agent, Timolol maleate. Because the topical application can result in systemic absorption, the officially documented safety profile includes both local ocular effects and the potential for adverse reactions associated with oral beta-blockers.

Adverse Reactions by System and Frequency

Adverse reactions are formally classified by frequency (e.g., Common, Uncommon, Rare) and grouped by System Organ Class in regulatory labeling.

Classification Examples of Officially Listed Adverse Reactions
Common Headache, signs of ocular irritation (e.g., burning, stinging, itching, redness), and blurred vision.
Uncommon/Rare Systemic effects such as dizziness, depression, bradycardia (slow heart rate), hypotension (low blood pressure), and symptoms of cardiac failure.

Serious Adverse Reactions and Safety Constraints

The regulatory label highlights potentially serious events and explicit safety restrictions, primarily due to the drug's systemic beta-blocking activity:

  • Cardiopulmonary Risks: Severe respiratory reactions, including death due to bronchospasm in susceptible patients, and cardiac arrest have been reported. The risk of cardiac failure (new onset or worsening) exists due to continued depression of the myocardium.
  • Contraindications: The medicine is strictly contraindicated for use in individuals with pre-existing conditions sensitive to beta-blockade, including bronchial asthma, severe chronic obstructive pulmonary disease (COPD), sinus bradycardia, second- or third-degree atrioventricular block, and overt cardiac failure.
  • Population Safety Notes: Caution is necessary in patients with diabetes, as beta-blockers may mask the signs of acute hypoglycemia. Similarly, signs of hyperthyroidism may be masked. Beta-adrenergic blockade may also potentiate muscle weakness in patients with myasthenia gravis.

The official safety information structures the understanding of risks by establishing that the pharmacological class of Timolol maleate dictates a potential for systemic adverse effects despite topical administration. This results in formal contraindications in conditions where beta-blockade is hazardous.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The following information details the officially documented overdose manifestations and mandated emergency actions for this ophthalmic solution, based on regulatory prescribing information.


Overdose Scope and Manifestations

Classification Documented Presentations
Cardiovascular Bradycardia (slow heart rate), hypotension (low blood pressure), heart block (second or third degree), acute cardiac failure, and cardiac arrest are severe, documented outcomes.
Respiratory Bronchospasm and shortness of breath are recognized manifestations, particularly in individuals with pre-existing conditions.
Nervous System Signs include dizziness, drowsiness, confusion, and potentially convulsions or coma in severe cases.

Emergency Actions and Supportive Care

  • When immediate medical help is required: Due to the potential for severe, life-threatening outcomes, including acute cardiac or respiratory failure, individuals must seek immediate medical attention and contact emergency services upon suspected overdose.
  • Required actions: Individuals should contact a Poison Control Centre or proceed to a hospital emergency department immediately.
  • Supportive treatment: Management is primarily symptomatic and supportive. Interventions described in regulatory texts include the use of Atropine sulphate or a cardiac pacemaker for persistent bradycardia, and the use of sympathomimetic pressor agents (e.g., Glucagon) for severe hypotension. Gastric lavage or activated charcoal may be used following oral ingestion, as the active ingredient does not dialyse readily.

Population-Specific Overdose Notes

Regulatory sources indicate that neonates, infants, and younger children require extreme caution due to the possibility of severe complications, including apnoea (cessation of breathing) and Cheyne-Stokes breathing.


The regulatory profile defines overdose by outlining the expected systemic effects of beta-blockade and mandates immediate medical intervention due to the risk of severe cardiorespiratory events. This information specifies both the severe outcomes and the pharmacological and procedural steps necessary for supportive management.

Advertisements

Therapeutic Uses of Timolol 0.5% Wockhardt

Timolol 0.5% Wockhardt ophthalmic solution is commonly used for managing conditions associated with a key risk factor for vision loss: elevated intraocular pressure (IOP). This therapeutic approach is utilized in clinical contexts that require the sustained management of intraocular pressure.


Treatment and Benefits

This medication is commonly used to help with patients diagnosed with ocular hypertension (high pressure in the eye) and chronic open-angle glaucoma. It may also assist in more complex clinical contexts, including secondary glaucoma and management for aphakic patients with glaucoma. The medication is applied in addressing the reduction and sustained management of this elevated intraocular pressure.

“The medication is commonly used to help with the management of conditions characterized by periods of heightened physiological stress, such as consistently high eye pressure.”

In a long-term context, the medication may assist with providing support for the optic nerve. This control contributes to maintaining existing vision and supports coping with potential visual field loss. It is often employed alongside other anti-glaucoma medications when additional symptomatic support is needed for pressure management.


Quick Fact: Support for Elevated Intraocular Pressure

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Timolol 0.5% Wockhardt?

Eligibility for this medicine is strictly determined by its official regulatory status, primarily due to the risk of systemic absorption of the beta-blocker component. The medicine is generally eligible for adults with ocular hypertension or chronic open-angle glaucoma.

Absolute Non-Eligibility (Contraindications)

This medication must not be used by patients with the following conditions, as stated in prescribing information:

Contraindicated Condition Rationale (Regulatory Basis)
Bronchial Asthma or a history of asthma Risk of severe respiratory effects
Severe Chronic Obstructive Pulmonary Disease (COPD) Risk of respiratory distress
Sinus Bradycardia (slow heart rate) Risk of critical cardiac depression
Overt Cardiac Failure or Cardiogenic Shock Risk of worsening heart failure

Restricted or Conditional Use

Use is not recommended during pregnancy unless clearly deemed necessary, and caution is advised during breastfeeding. Safety and efficacy have not been established in children younger than 2 years of age. Eligibility is restricted for patients with impaired hepatic or renal function, requiring potential dosage adjustment, and for those with diabetes mellitus due to the possibility of masking hypoglycemia symptoms. Patients with soft contact lenses must remove them before application.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines documented interaction patterns based strictly on official regulatory prescribing information. The ophthalmic solution's active ingredient, Timolol maleate, can be systemically absorbed, leading to potential drug–drug interactions.

Interaction Type Interacting Agents and Outcome
Pharmacodynamic Additive Effects Co-administration with oral calcium channel blockers, antiarrhythmics (e.g., Amiodarone), and catecholamine-depleting drugs (e.g., Reserpine) may result in additive effects leading to hypotension and/or marked bradycardia (slow heart rate).
Metabolic Exposure Modification Medicines identified as strong CYP2D6 inhibitors (e.g., Quinidine, Fluoxetine, Paroxetine) have been reported to increase the plasma concentration of Timolol, potentially leading to potentiated systemic beta-blockade.

Restrictions and Specific Cautions

Official regulatory documents state that the concomitant use of two topical beta-adrenergic blocking agents is not recommended due to the risk of additive ocular and systemic effects. Additionally, in individuals receiving antidiabetic agents, Timolol may mask the signs and symptoms of acute hypoglycemia. If using contact lenses, the procedural requirement is to remove the lenses prior to application and wait 15 minutes before reinsertion.

Advertisements

Mechanism of Action

Timolol 0.5% Wockhardt is a non-selective beta-adrenergic receptor antagonist. When topically administered to the eye, the active agent, timolol maleate, acts through competitive binding to beta1 and beta2 adrenergic receptors. These receptors are primarily situated on the non-pigmented epithelial cells of the ciliary body. The drug occupies the binding sites, preventing the native signaling molecules—epinephrine and norepinephrine—from engaging the receptors. This blockade initiates an intracellular cascade by uncoupling the receptor from its G-protein, thereby interfering with the activation of the membrane-bound enzyme, adenylate cyclase. The consequence of this enzymatic inhibition is a resultant reduction in the intracellular concentration of the second messenger, cyclic adenosine monophosphate (cAMP). The diminished concentration of cAMP directly modulates the ion and fluid transport processes within the ciliary epithelium, leading to a profound decrease in the active secretion rate of aqueous humor into the posterior chamber of the eye. The lowered production of aqueous humor represents the final, system-level physiological consequence of this localized receptor antagonism.

Advertisements

Dosage and Administration Information

How to Use Timolol 0.5% Wockhardt

This section describes the general administration principles for Timolol 0.5% ophthalmic solution.


Administration Scope

Feature Guideline
Route of administration The product is restricted to topical ophthalmic use, meaning instillation directly onto the eye surface.
Dosing schedule The standard dose is one drop of the 0.5% solution applied to the affected eye(s) per dosing interval.
Frequency and Timing Administration is either once daily (often in the morning) or twice daily, depending on the specific preparation and the pressure response achieved.
Missed-dose rules If a dose is missed, it should be administered as soon as remembered, unless the time for the next scheduled dose is imminent, in which case the missed dose must be skipped to avoid using a double dose.

Special Procedural Conditions

  • Concurrent Eye Drops: A minimum interval of 5 to 10 minutes is required between the application of Timolol 0.5% and any other topical ophthalmic medication.
  • Contact Lenses: Soft contact lenses must be removed prior to administration and can be reinserted 15 minutes after the drops are instilled.
  • Geriatric Use: Observations have shown no overall differences in administration or effectiveness between older and younger adult patients, allowing for the standard adult regimen.
  • Pediatric Use: Use is generally reserved for transitional periods. The lowest available concentration is typically recommended once daily, with titration to a maximum of two drops daily per affected eye if required.

These instructions define the parameters—the topical route, the fixed volume of one drop, and the daily frequency—which are maintained during the course of treatment to ensure proper delivery and minimize systemic effects. The full pressure-lowering response may take approximately four weeks to stabilize.

Advertisements

Recent Clinical Evidence

Timolol 0.5% Wockhardt: Recent Clinical Evidence


Evidence for use in Ocular Hypertension

Research exploring the use of Timolol ophthalmic solution was studied for conditions involving elevated pressure inside the eye, known as ocular hypertension. Researchers utilized Randomized Controlled Trials (RCTs) to compare the solution against an inactive eye drop or other standard treatments. Studies focused primarily on measuring and tracking changes in Intraocular Pressure (IOP). Studies reported measurements of pressure change in the patient groups being observed compared to control groups. This evidence contributes to the broader evidence landscape supporting the medication's presence in the research base for this condition. However, insight into very long-term outcomes (beyond ten years) is limited, and data for certain groups with specific concurrent health issues may be limited.


Evidence for use in Chronic Open-Angle Glaucoma

For chronic open-angle glaucoma, the medicine was evaluated in a large number of clinical trials, frequently being used as a standard comparator agent. Studies focused on monitoring two main areas: measuring changes in IOP and tracking visual field measurements over time. Studies reported that groups receiving the medication were observed to have a slower rate of visual field change over multi-year periods compared to control groups. Research for very specific subgroups, such as those with low baseline pressure measurements, remains smaller.


Long-Term Studies and Limitations

A significant amount of research has explored the long-term use of the solution. The goal was to track the stability of intraocular pressure measurements over time. Research describes the maintenance of pressure changes over sustained treatment periods. However, the available evidence is limited in certainty regarding the absolute stability of the measured changes over a lifetime, as patient drop-out from studies can impact the interpretation of results. Furthermore, comparative evidence is lacking for a direct assessment against all newer classes of glaucoma medications using a consistent functional outcome.


Evidence in Special Populations

The research has also examined the use of this ophthalmic solution in specific patient groups beyond the general adult population. Dedicated, smaller RCTs was evaluated in pediatric populations, including infants, children, and adolescents. Further studies also include specific research on patients who have had prior cataract surgery (aphakic patients with glaucoma). Conversely, data for certain other groups, such as pregnant populations or those with specific systemic or functional imbalances, are still emerging or remain insufficient for drawing broad conclusions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Timolol 0.5% Wockhardt (FAQ)


Q: How quickly should I expect Timolol 0.5% Wockhardt to start lowering eye pressure?

A: The pressure-lowering effect of the eye drops can typically be detected within half an hour after a single dose is administered. According to official product information, the maximum reduction in eye pressure is usually achieved within one to two hours of use.


Q: What happens if I accidentally miss a dose of Timolol 0.5% Wockhardt?

A: Official instructions indicate that if a dose is missed, it should be administered as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to prevent using a double dose. Official guidelines state that a double dose should not be used to make up for the one that was missed.


Q: How long does the pressure-lowering effect of one dose of Timolol 0.5% Wockhardt usually last?

A: Studies and official information indicate that a significant reduction in intraocular pressure (IOP) can be maintained for as long as 24 hours after one dose. The long duration of action supports its use in various daily dosing regimens.


Q: Are there specific types of contact lenses I should avoid while using Timolol 0.5% Wockhardt?

A: Soft contact lenses must be removed before the drops are administered to the eye. This is because the lenses can absorb the preservative (if present in the formulation). The recommended procedure is to wait at least 15 minutes after administering the drops before reinserting soft contact lenses.


Q: Can Timolol 0.5% Wockhardt interact with common over-the-counter pain relievers?

A: Official reports indicate that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class of common pain relievers, may sometimes counteract the blood pressure-lowering effect of beta-blockers. This risk highlights the need to ensure all medications, including over-the-counter products, are reviewed by a healthcare provider.


Q: Does Timolol 0.5% Wockhardt interact with antidepressant medications?

A: Yes, potentiated (increased) systemic beta-blockade has been reported when timolol is used with certain CYP2D6 inhibitors. These inhibitors include the active ingredients found in some antidepressant medications, such as fluoxetine and paroxetine. This combination may lead to effects like a significantly decreased heart rate.


Q: Can cold or flu medicines affect the performance of Timolol 0.5% Wockhardt?

A: Close observation is recommended when using timolol with catecholamine-depleting drugs (like reserpine), which are sometimes found in cold and flu products. This is due to the possible risk of combined effects, which could potentially cause a drop in blood pressure or a marked slowing of the heart rate.


Q: Does the 0.5% concentration mean Timolol is a stronger dose?

A: Timolol ophthalmic solution is commonly available in two concentrations: 0.25% and 0.5%. The 0.5% concentration does contain a higher amount of the active ingredient (timolol maleate) per milliliter compared to the 0.25% strength. The appropriate strength is determined by a healthcare provider based on the individual treatment plan.


Q: Are there any foods or drinks that should be avoided while using Timolol 0.5% Wockhardt?

A: No specific food or drink restrictions are typically listed for this eye drop. However, because the drug is absorbed systemically, using it with alcohol may lead to additive effects that lower blood pressure, which could potentially cause dizziness. It is important to understand this potential effect.


Q: Are there any common vision changes people report when first using Timolol 0.5% Wockhardt?

A: Commonly reported adverse effects in the eye include blurred vision and signs of ocular irritation. Ocular irritation can present as burning, stinging, itching, or redness. Any persistent or severe effects should be reported to a healthcare provider.


Q: Why is my eye pressure checked regularly after starting Timolol 0.5% Wockhardt?

A: Regular visits to the eye doctor are necessary to ensure the medication is working effectively to control eye pressure. The check-ups also allow the doctor to monitor for any unwanted local or systemic effects of the medicine.


Q: Does Timolol 0.5% Wockhardt cause stinging or burning when you put it in?

A: Yes, ocular irritation is a commonly reported adverse reaction, which includes sensations like burning and stinging in the eye. While this is common, any severe or persistent discomfort should be reported to a doctor.


Q: What are the signs of an allergic reaction to Timolol 0.5% Wockhardt?

A: Signs of a potential allergic reaction listed in official documents may include a generalized or localized rash, itching, or swelling of the face, tongue, or throat (angioedema). More severe but rare reactions like anaphylaxis have also been reported.


Q: Does the Wockhardt brand of Timolol 0.5% have a preservative in it?

A: Timolol ophthalmic solutions come in formulations that may contain a preservative, such as benzalkonium chloride (BAC), or as preservative-free unit-dose containers. Information regarding the presence of preservatives is typically found in the specific packaging or patient information leaflet.


Q: What is the shelf life of Timolol 0.5% Wockhardt once the bottle is opened?

A: To maintain product stability and sterility, official information advises that the eye drop solution must be discarded 28 days or one month after the bottle is first opened. This rule applies even if some medication remains in the container.


Q: What research shows that Timolol 0.5% Wockhardt is effective for lowering eye pressure?

A: The effectiveness of Timolol ophthalmic solution in reducing elevated eye pressure is supported by results from clinical trials, including Randomized Controlled Trials (RCTs). These studies have consistently demonstrated that the medication effectively lowers intraocular pressure and that this effect is maintained over time.


Q: Why is the drug called Timolol and how does it relate to the 0.5% concentration?

A: Timolol is the generic name for the active chemical compound that works as a beta-blocker to lower eye pressure. The 0.5% concentration refers to the weight/volume percentage of the active ingredient (timolol maleate) included in the liquid ophthalmic solution.


Q: Do older people experience different side effects from Timolol 0.5% Wockhardt compared to younger adults?

A: Official product labels indicate that there have been no overall differences observed in either the effectiveness or the safety profile between older and younger adult patients. Therefore, the standard adult regimen is generally applicable.


Q: Can Timolol 0.5% Wockhardt cause light sensitivity or blurry vision temporarily?

A: Adverse reactions reported in official documents include both blurred vision and an increase in sensitivity of the eyes to light (known as photophobia). Persistent effects should be reported to a healthcare provider for review.


Q: Is it normal to feel a bitter taste in your mouth after using Timolol eye drops?

A: Yes, taste changes, often described as a bitter or unusual taste, have been reported as a common side effect of ophthalmic timolol. This is thought to occur when the medicine drains from the eye into the nasal passages and throat.


Q: Does the generic Timolol 0.5% work exactly the same way as the brand name?

A: In principle, generic versions of Timolol 0.5% are required by regulatory bodies to be bioequivalent to the original branded product. This means they must contain the same active ingredient and achieve the same therapeutic effect by working in the same way.


Q: Why do some doctors suggest pressing on the tear duct after using eye drops like Timolol?

A: This technique, called punctal occlusion, is recommended in some patient instructions as a way to help limit the systemic absorption of the medicine into the rest of the body. By reducing drainage through the tear duct, less of the drug is available to enter the bloodstream.


Q: Does Timolol 0.5% Wockhardt carry a risk of hair loss or changes in skin color?

A: Systemic adverse reactions reported include alopecia (hair loss) and changes in the skin such as psoriasiform rash or the worsening of pre-existing psoriasis (a skin condition).


Q: How is the effectiveness of Timolol 0.5% Wockhardt measured by my eye doctor?

A: The primary clinical measure of the drug's effectiveness, as highlighted in studies, is its ability to reduce and maintain control of Intraocular Pressure (IOP). Your eye doctor will monitor this pressure during your regular follow-up visits.


Q: What should I do if the Timolol 0.5% Wockhardt solution changes color or looks cloudy?

A: Official patient information advises that if the solution changes color, becomes cloudy, or is suspected of being contaminated, you should seek your physician’s advice before continuing to use that container. Never use eye drops that appear compromised.


Q: Is it important to tilt my head back a certain way when applying Timolol 0.5% Wockhardt?

A: Patient instructions typically recommend that you tilt your head backwards or lie down for ease of application. This helps create a pocket between the eye and lower eyelid to properly receive the drop.


Q: How does Timolol 0.5% Wockhardt lower intraocular pressure without affecting vision?

A: Timolol works by decreasing the rate at which the aqueous humor fluid is produced inside the eye. The regulatory information notes that Timolol has little or no effect on the pupil, which helps preserve typical visual function.


Q: Is Timolol 0.5% Wockhardt known to cause issues with sleep or fatigue?

A: Systemic side effects that have been reported include central nervous system (CNS) effects such as insomnia (difficulty sleeping) and nightmares. Official documents also list fatigue (tiredness) as a reported adverse reaction.


Q: What percentage of people experience the more serious side effects of Timolol 0.5% Wockhardt?

A: Official labeling typically does not provide an exact percentage for all serious adverse effects. Instead, they are classified by frequency based on clinical reporting, with serious systemic effects generally categorized as Uncommon or Rare.


Q: Is Timolol 0.5% Wockhardt used for any conditions other than glaucoma?

A: Official indications state that Timolol ophthalmic solution is used to treat elevated intraocular pressure in patients with chronic open-angle glaucoma and in those with ocular hypertension (high eye pressure without optic nerve damage).


Q: Why is it important to keep the tip of the Timolol 0.5% Wockhardt dropper sterile?

A: It is crucial to avoid touching the dropper tip against the eye or any surface because contamination can occur. Contaminated eye solutions carry the risk of causing serious damage to the eye, including the potential for loss of vision.

Advertisements

How should Timolol 0.5% Wockhardt be stored and disposed of?

How to Store and Dispose of Timolol 0.5% Ophthalmic Solution

The storage and disposal of Timolol 0.5% Ophthalmic Solution must adhere strictly to official regulatory labeling to maintain product stability and safety.

Storage Requirements

The medicine must be stored at room temperature, typically between 15 C and 25 C. The solution must be protected from freezing and kept out of light, requiring storage in its original outer carton. The container should be kept tightly closed when not in use. For stability, any unused portion of the solution must be discarded 28 days or one month after the bottle is first opened.

Child Safety and Disposal

Timolol 0.5% Ophthalmic Solution must be stored out of the reach and sight of children. Disposal of any unused or expired product must be done in accordance with local regulations, often through a formal medicine take-back program or as advised by a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Timolol 0.5% Wockhardt found in:

A-Z Index: